← Back to Search

Insulin

FiAsp - 120-minutes postprandial exercise for Type 1 Diabetes

Phase 4
Waitlist Available
Led By Remi Rabasa-Lhoret
Research Sponsored by Institut de Recherches Cliniques de Montreal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 minutes after the end of exercise
Awards & highlights

Study Summary

This trial will compare the impacts of two types of insulin on blood sugar levels during exercise for people with type 1 diabetes.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 minutes after the end of exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 minutes after the end of exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decrease in plasma glucose levels during exercise
Secondary outcome measures
Amount of carbohydrates needed to treat a hypoglycemic event
Area under the curve of plasma glucose levels
Area under the curve of plasma glucose levels below 4 mmol/L
+13 more

Trial Design

4Treatment groups
Active Control
Group I: FiAsp - 120-minutes postprandial exerciseActive Control2 Interventions
Group II: Aspart - 60-minutes postprandial exerciseActive Control2 Interventions
Group III: FiAsp - 60-minutes postprandial exerciseActive Control2 Interventions
Group IV: Aspart - 120-minutes postprandial exerciseActive Control2 Interventions

Find a Location

Who is running the clinical trial?

Institut de Recherches Cliniques de MontrealLead Sponsor
70 Previous Clinical Trials
10,328 Total Patients Enrolled
Remi Rabasa-LhoretPrincipal InvestigatorInstitut de recherches cliniques de Montréal
9 Previous Clinical Trials
6,185 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes
2019. "Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03659799.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top